In patients with IBD, the application of cannabis, a cannabinoid receptor 2 (CB2R) agonist, was shown to alleviate the severity of IBD via the induction of autophagy and suppression of macrophage-mediated inflammation (Tartakover Matalon et al., 2020). Here, CNR2 is linked to inflammatory bowel disease.